The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $38.36 in the prior trading day, Marex Group Plc (NASDAQ: MRX) closed at $37.94, down -1.09%. In other words, the price has decreased by -$1.09 from its previous closing price. On the day, 0.72 million shares were traded. MRX stock price reached its highest trading level at $38.755 during the session, while it also had its lowest trading level at $37.84.
Ratios:
Our goal is to gain a better understanding of MRX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.20 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.35. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 7.45 whereas as Long-Term Debt/Eq ratio is at 2.31.
Upgrades & Downgrades
In the most recent recommendation for this company, TD Cowen on July 14, 2025, initiated with a Buy rating and assigned the stock a target price of $54.
On March 10, 2025, HSBC Securities Downgraded its rating to Hold which previously was Buy and also upped its target price recommendation from $33 to $36.
On November 21, 2024, HSBC Securities started tracking the stock assigning a Buy rating and target price of $33.HSBC Securities initiated its Buy rating on November 21, 2024, with a $33 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 24 ’25 when Sarah Ing bought 6,813 shares for $31.70 per share.
Nilesh Kumar Jethwa bought 105,637 shares of MRX for $3,685,675 on Nov 12 ’25. On Oct 06 ’25, another insider, Simon Van Den Born, who serves as the Officer of the company, bought 56,000 shares for $29.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRX now has a Market Capitalization of 2765790976 and an Enterprise Value of 2489282560. As of this moment, Marex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.95, and their Forward P/E ratio for the next fiscal year is 8.89. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.93 while its Price-to-Book (P/B) ratio in mrq is 2.51. Its current Enterprise Value per Revenue stands at 0.933.
Stock Price History:
The Beta on a monthly basis for MRX is -0.69, which has changed by 0.16666663 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, MRX has reached a high of $49.34, while it has fallen to a 52-week low of $27.91. The 50-Day Moving Average of the stock is 7.95%, while the 200-Day Moving Average is calculated to be 2.30%.
Shares Statistics:
The stock has traded on average 728.90K shares per day over the past 3-months and 438030 shares per day over the last 10 days, according to various share statistics. A total of 71.70M shares are outstanding, with a floating share count of 53.31M. Insiders hold about 25.16% of the company’s shares, while institutions hold 73.18% stake in the company. Shares short for MRX as of 1765756800 were 2501256 with a Short Ratio of 3.43, compared to 1763078400 on 2875545. Therefore, it implies a Short% of Shares Outstanding of 2501256 and a Short% of Float of 7.670000000000001.
Earnings Estimates
As of right now, 4.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $1.01, with high estimates of $1.11 and low estimates of $0.91.
Analysts are recommending an EPS of between $3.91 and $3.85 for the fiscal current year, implying an average EPS of $3.89. EPS for the following year is $4.19, with 7.0 analysts recommending between $4.57 and $3.71.
Revenue Estimates
1 analysts predict $529.08M in revenue for. The current quarter. It ranges from a high estimate of $529.08M to a low estimate of $529.08M. As of. The current estimate, Marex Group Plc’s year-ago sales were $415.6MFor the next quarter, 1 analysts are estimating revenue of $509.7M. There is a high estimate of $526M for the next quarter, whereas the lowest estimate is $482.9M.
A total of 2 analysts have provided revenue estimates for MRX’s current fiscal year. The highest revenue estimate was $1.97B, while the lowest revenue estimate was $1.96B, resulting in an average revenue estimate of $1.97B. In the same quarter a year ago, actual revenue was $1.59BBased on 6 analysts’ estimates, the company’s revenue will be $2.08B in the next fiscal year. The high estimate is $2.27B and the low estimate is $1.86B.
